| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.003 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.098 | 0.004 |